Investing Insmed stock plunges after failed Phase 2b study in CRSsNP Dylan D. DavisDecember 17, 2025 Insmed stock plunges after failed Phase 2b study in CRSsNP Source link
Energy Fuels exceeds 2025 uranium production and sales guidance Energy Fuels exceeds 2025 uranium production and sales guidance Source link
Greenfire stock rises after completion of C$300 million refinancing Greenfire stock rises after completion of C$300 million refinancing Source link
Two plays on the senior housing boom can rally more than 20%, Goldman says Goldman Sachs sees big opportunities in two real estate stocks that it says will benefit from the booming senior population.…
